World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
23233
World Ranking
16688
National Ranking
550

Gérard Milano publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gérard Milano sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 522 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gérard Milano D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gérard Milano sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gérard Milano is affiliated with Université Côte d'Azur in France and has contributed extensively to research in medicine and biochemistry, genetics, and molecular biology. Their work primarily focuses on oncology and related subfields, with significant output in cancer research and molecular biology.

Their research covers multiple specific topics, including:

  • Colorectal Cancer Treatments and Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • SARS-CoV-2 and COVID-19 Research
  • Cancer Treatment and Pharmacology
  • COVID-19 Clinical Research Studies

Some notable recent publications authored or co-authored by Gérard Milano include:

  • "Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs," 2022, Cancer Science
  • "All You Need to Know About DPYD Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly Guide," 2020, JCO Oncology Practice
  • "Host Polymorphisms May Impact SARS-CoV-2 Infectivity," 2020, Trends in Genetics
  • "PD-L1 regulation revisited: impact on immunotherapeutic strategies," 2021, Trends in Molecular Medicine
  • "COVID-19 vaccine race: watch your step for cancer patients," 2020, British Journal of Cancer

Frequent co-authors collaborating with Gérard Milano include:

  • Jocelyn Gal
  • Patrick Brest
  • Baharia Mograbi
  • Paul Hofman
  • Joseph Ciccolini

Their publications appear frequently in journals such as:

  • British Journal of Cancer
  • Trends in Genetics
  • Annals of Oncology
  • Cancer Chemotherapy and Pharmacology
  • International Journal of Molecular Sciences

Best Publications

  • Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value

    Laetitia Marisa;Aurélien de Reyniès;Alex Duval;Alex Duval;Janick Selves

  • Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.

    O Dassonville;J L Formento;M Francoual;A Ramaioli

  • Population study of dihydropyrimidine dehydrogenase in cancer patients.

    M C Etienne;J L Lagrange;O Dassonville;R Fleming

  • Impact of EGFR expression on colorectal cancer patient prognosis and survival

    J.-P. Spano;C. Lagorce;D. Atlan;G. Milano

  • Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

    M C Etienne;S Chéradame;J L Fischel;P Formento

  • Management of hypertension in angiogenesis inhibitor-treated patients

    H. Izzedine;S. Ederhy;F. Goldwasser;J.C. Soria

  • A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.

    A. Beck;M.C. Etienne;S. Chéradame;J.L. Fischel

  • Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas.

    José Santini;Jean-Louis Formento;Mireille Francoual;Gérard Milano

  • Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.

    Ronald A. Fleming;Gerard Milano;Antoine Thyss;Marie-Christine Etienne

  • Influence of sex and age on fluorouracil clearance.

    G Milano;M C Etienne;E Cassuto-Viguier;A Thyss

  • Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen.

    Antoine Thyss;Johanna Kubar;Gerard Milano;Moise Namer

  • Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity.

    G Milano;M C Etienne;V Pierrefite;M Barberi-Heyob

  • Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate.

    Jean-Pierre Caussanel;Francis Lévi;Silvano Brienza;Jean-Louis Misset

  • Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines

    Daniel G. Haller;Jim Cassidy;Stephen J. Clarke;David Cunningham

  • Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

    Dan Rosmarin;Claire Palles;David Church;Enric Domingo

  • Known variant DPYD alleles do not explain DPD deficiency in cancer patients.

    E. S. R. Collie-Duguid;M. C. Etienne;G. Milano;H. L. Mcleod

  • 5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer.

    J Santini;G Milano;A Thyss;N Renee

  • Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives

    J.P. Spano;R. Fagard;J.-C. Soria;O. Rixe

  • Circadian Rhythm-varying Plasma Concentration of 5-Fluorouracil during a Five-Day Continuous Venous Infusion at a Constant Rate in Cancer Patients

    Emmanuel Petit;Gérard Milano;Francis Lévi;Antoine Thyss

  • Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: Phenotypic and genotypic analyses

    Marie-Christine Etienne;Maurice Chazal;Pierre Laurent-Puig;Nicolas Magné

Frequent Co-Authors

Pierre Laurent-Puig
Pierre Laurent-Puig Université Paris Cité
Valérie Boige
Valérie Boige Institut Gustave Roussy
Thierry André
Thierry André Université Paris Cité
Paul Hofman
Paul Hofman Grenoble Alpes University
Frédérique Penault-Llorca
Frédérique Penault-Llorca University of Clermont Auvergne
René Adam
René Adam University of Paris-Saclay
Aimery de Gramont
Aimery de Gramont Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in medicine opens doors to many online academic and vocational options beyond the traditional MD path. For working professionals seeking upward mobility, online DNP programs are gaining popularity. Some dnp programs without dissertation allow for an efficient, research-focused approach that can be completed while balancing work and personal life.

If you want to start your healthcare career quickly, lpn online programs are an accessible option. These fast-track programs address a high demand for allied health professionals and are designed for speedy entry to the workforce.

Specialized nursing is another area with strong online pathways. Mental health is a growing field, and the fastest pmhnp program choices can help nurses become certified Psychiatric Mental Health Nurse Practitioners in less time.

Not all routes require clinical practice. For those interested in leadership, the cheapest online healthcare administration degree options make pursuing a management role in healthcare accessible and affordable.

Best Scientists Citing Gérard Milano

Trending Scientists

Recently Published Articles